YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Changes in Fitness and Strength in Postoperative Cardiac Patients Undergoing Exercise Therapy: Biological and Functional Mechanisms of Recovery
Not Applicable
Completed
- Conditions
- Cardiorespiratory; Insufficiency, Due to A Procedure, Long-Term, Cardiac Surgery
- Interventions
- Behavioral: Cardiac Exercise Program
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 9
- Registration Number
- NCT04903691
- Locations
- 🇺🇸
Yale Church Street Research Unit (CSRU), New Haven, Connecticut, United States
Acute Effects of Vaping Nicotine on Cognition in Young Adults
Not Applicable
Completed
- Conditions
- Nicotine AddictionVaping
- Interventions
- Drug: Placebo pod
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 8
- Registration Number
- NCT04901208
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
Not Applicable
Active, not recruiting
- Conditions
- Epilepsy, Temporal Lobe
- Interventions
- Device: Central Thalamic StimulationDevice: Hippocampal Stimulation
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5
- Registration Number
- NCT04897776
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Quit Nicotine: E-Cig Cessation Intervention
Not Applicable
Completed
- Conditions
- E-Cig Use
- Interventions
- Behavioral: Remote Contingency Management (CM) for nicotine abstinenceOther: Control
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Yale University
- Target Recruit Count
- 108
- Registration Number
- NCT04898075
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
Early Phase 1
Completed
- Conditions
- Alcohol DrinkingDrinking BehaviorEpisodic MemoryLong-term Memory
- Interventions
- Other: Placebo
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Yale University
- Target Recruit Count
- 27
- Registration Number
- NCT04896489
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Multisite Tissue Oxygenation Guided Perioperative Care in Cardiac Surgery
Not Applicable
Completed
- Conditions
- Muscle; IschemicBrain Ischemia HypoxiaMuscle Hypoxia
- Interventions
- Other: Multisite tissue oxygenation-guided careOther: Usual care
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 1960
- Registration Number
- NCT04896736
- Locations
- 🇨🇳
Tianjin Chest Hospital, Tianjin, Tianjin, China
Yale COVID-19 Recovery Study
Completed
- Conditions
- Covid19 Sequelae
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Yale University
- Target Recruit Count
- 16
- Registration Number
- NCT04895189
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
Digital Interventions to Treat Hazardous Drinking
Not Applicable
Completed
- Conditions
- StressHazardous Drinking
- Interventions
- Behavioral: Digital intervention
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Yale University
- Target Recruit Count
- 33
- Registration Number
- NCT04890652
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Reducing Depression-related Stigma and Increasing-treatment Seeking Among Black Adolescents
Not Applicable
Completed
- Conditions
- DepressionRacism
- Interventions
- Behavioral: Short videos
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 1291
- Registration Number
- NCT04890990
- Locations
- 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States
Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.
Phase 4
Terminated
- Conditions
- Multiple SclerosisRadiologically Isolated Syndrome
- Interventions
- Other: Placebo
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 3
- Registration Number
- NCT04877457
- Locations
- 🇺🇸
Cleveland Clinic Melen Center, Cleveland, Ohio, United States
🇺🇸Yale University, North Haven, Connecticut, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath